Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferric Carboxymaltose vs Iron Isomaltoside 1000 in Iron-Deficiency Anemia
DRKS00010766Phase 4Completed
- Sponsor
- Saarland University
- Start
- Jun 2016
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA) comparing Ferric carboxymaltose (Ferinject) with Iron isomaltoside 1000 (Monofer) (2 arms). Primary endpoint: Plasma phosphate levels after treatment. Started Jun 2016; status: completed.
02
Drugs
ferric carboxymaltoseferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on DRKS00010766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00010766.